Imaging groups weigh in on CT lung screening vote


MITA also expressed dismay but remained confident that CT lung cancer screening will be covered eventually. “Making LDCT available to Medicare beneficiaries is in the best interest of the Medicare program and the patients it serves,” said Gail Rodriguez, MITA’s executive director. “We believe CMS will consider the overwhelming evidence and make this lifesaving service available to beneficiaries.”


Click here to read the full article.